Clarithromycin Dispersible Tablets can be taken by children over six months of age, and the safety and efficacy of the drug in children under six months of age are not known. Pediatric patients should use the drug reasonably with the help of guardians and after consulting with professional pediatricians. Clarithromycin dispersible tablets are mainly used for infections caused by clarithromycin-sensitive bacteria, including: nasopharyngeal infections; lower respiratory tract infections; skin and soft tissue infections; acute otitis media, Mycoplasma pneumoniae pneumonia, Chlamydia trachomatis leading to urethritis and cervicitis, etc.; also used for Legionella infections, or the combined treatment of Mycobacterium avium infections, Helicobacter pylori infections. Adverse reactions of clarithromycin dispersible tablets include: oral odor, abdominal pain, diarrhea, nausea, vomiting, headache, transient elevation of serum aminotransferase; allergic reactions, such as drug rash or urticaria in mild cases, and STEVENS-JOHNSON’S DISEASE in severe cases; hepatotoxicity, pseudomembranous enterocolitis caused by Clostridium difficile; transient central nervous system reactions, such as anxiety, dizziness, insomnia, hallucinations, etc. In addition, patients who are allergic to clarithromycin dispersible tablets or macrolides are prohibited, pregnant and lactating women are prohibited, severe hepatic impairment, water-electrolyte disorders, certain cardiac diseases, patients taking terfenadine treatment are prohibited, hepatic impairment, moderate-to-severe renal impairment of patients with caution. If you need to use Clarithromycin dispersible tablets for children patients, please with the help of a guardian, follow the doctor’s instructions to standardize the use of medication.